5 results match your criteria: "ASL Pescara General Hospital[Affiliation]"
Eur J Clin Pharmacol
March 2024
Hospital Pharmacy of Corato, Local Health Unit of Bari, Corato, Italy.
Introduction: In recent years, the consumption of antidepressants has arisen. However, deprescribing antidepressant therapy is very complicated. The aim of this study was to implement practical recommendations for the development of guidelines to be used for antidepressant deprescription in clinical practice.
View Article and Find Full Text PDFCurr Med Res Opin
February 2022
ASL Pescara General Hospital, Pescara, Italy.
Introduction: At this time in history fraught with restrictions and issues stemming from the COVID-19 pandemic, the care and management of chronic therapies is a major concern for society. The objective of the following study was to assess whether adherence and persistence in patients treated with hypoglycaemic drugs and statins during 2020 changed in comparison with pre-pandemic years.
Materials And Methods: A retrospective study was conducted, taking into account the drugs dispensed at pharmacies in the territory of the ASL (Local Health Authority) of Pescara from January 1, 2011 to December 2020 of all patients treated with ATC A10B (hypoglycaemic group) and ATC C10A (statin group).
Int J Clin Pract
June 2021
ASL Pescara General Hospital, Pescara, Italy.
Introduction: Non-adherence to therapy is very common in patients with type II diabetes, leading to an increase in morbidity and mortality. The development of new oral therapies following metformin has increased the possibilities of treatment but little has been done in terms of improving medication adherence. The goal of the following study is to evaluate adherence and persistence over a period of 3 years in real-world diabetic patients and describe the comorbidities found in the group of patients studied.
View Article and Find Full Text PDFCurr Med Res Opin
December 2020
ASL Pescara General Hospital, Renato Paolini, Pescara, Italy.
Introduction: Low adherence and persistence values, which indicate real-life efficiency, have been widely reported in patients suffering from COPD (Chronic Obstructive Pulmonary Disease). Poor adherence may be related to treatment dosage, thus, simplifying the dosing regimen might improve adherence. The objective of the present study was either to evaluate adherence and persistence in primary drugs used in COPD treatment after 3 years in real life and assess whether the different dosing regimen affects adherence levels to therapy.
View Article and Find Full Text PDFCurr Rev Clin Exp Pharmacol
April 2022
ASL Pescara General Hospital, Member of Drug Utilization Research Group for Italian Society of Hospital Pharmacist (SIFO), Renato Paolini 47 65124, Pescara, Italy.
Background: Persistence and adherence to treatment are considered efficacy outcomes in psychiatric disorders. One of the best ways to improve these values in patients with psychiatric disorders is to prefer Long-Acting Injectable (LAI) drugs to oral AP.
Objective: The objective of this study is to evaluate adherence, persistence and switching of antipsychotics and compare in real life long-acting with oral formulations.